Aurinia Pharmaceuticals (AUPH) Work In Process (2023 - 2025)
Historic Work In Process for Aurinia Pharmaceuticals (AUPH) over the last 3 years, with Q3 2025 value amounting to $42.6 million.
- Aurinia Pharmaceuticals' Work In Process changed N/A to $42.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.6 million, marking a year-over-year change of. This contributed to the annual value of $36.6 million for FY2024, which is 201.47% down from last year.
- According to the latest figures from Q3 2025, Aurinia Pharmaceuticals' Work In Process is $42.6 million.
- Over the past 5 years, Aurinia Pharmaceuticals' Work In Process peaked at $43.2 million during Q2 2025, and registered a low of $36.6 million during Q4 2024.
- In the last 3 years, Aurinia Pharmaceuticals' Work In Process had a median value of $41.7 million in 2025 and averaged $40.3 million.
- Over the last 5 years, Aurinia Pharmaceuticals' Work In Process had its largest YoY gain of 201.47% in 2024, and its largest YoY loss of 201.47% in 2024.
- Aurinia Pharmaceuticals' Work In Process (Quarter) stood at $37.4 million in 2023, then decreased by 2.01% to $36.6 million in 2024, then rose by 16.42% to $42.6 million in 2025.
- Its Work In Process stands at $42.6 million for Q3 2025, versus $43.2 million for Q2 2025 and $41.7 million for Q1 2025.